The potential role of a self-management intervention for @entity31 : a brief report from the XXXX hypnotherapy trial.

@entity1 @entity3357 @entity31 @entity29 @entity33767
@entity29 ( @entity29 ) are chronic inflammatory illnesses marked by unpredictable disease flares, which occur spontaneously and/or in response to external triggers, especially personal health behaviors. Behavioral triggers of flare may be responsive to disease self-management programs. We report on interim findings of a randomized controlled trial of gut-directed hypnotherapy (HYP, n = 19) versus active attention control (CON, n = 17) for quiescent @entity31 ( @entity31 ). To date, 43 @entity1 have enrolled; after 5 discontinuations (1 in HYP) and 2 exclusions due to excessive missing data, 36 were included in this preliminary analysis. @entity33767 was to determine the feasibility and acceptability of HYP in @entity31 . This was achieved, demonstrated by a reasonable recruitment rate at our outpatient tertiary care clinic (20%), high retention rate (88% total), and our representative @entity29 sample, which is reflected by an equal distribution of gender, an age range between 21 and 69, recruitment of ethnic minorities (   20%), and disease duration ranging from 1.5 to 35 years. @entity3357 was to estimate effect sizes on key clinical outcomes for use in future trials. Effect sizes (group * time at 20 weeks) were small to medium for @entity29 self-efficacy (.34), Inflammatory Bowel Disease Questionnaire (IBDQ) total score (.41), IBDQ bowel (.50), and systemic health (.48). Between-group effects were observed for the IBDQ bowel health subscale (HYP > CON; p = .05) at 20 weeks and the Short Form 12 Health Survey Version 2 (SF-12v2) physical component (HYP > CON; p < .05) at posttreatment and 20 weeks. This study supports future clinical trials testing gut-directed HYP as a relapse prevention tool for @entity29 .
